Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 May 9;108(6):1272-1276.
doi: 10.4269/ajtmh.23-0004. Print 2023 Jun 7.

Vision Loss in Subacute Sclerosing Panencephalitis: A Systematic Review of Case Reports and Case Series

Affiliations
Case Reports

Vision Loss in Subacute Sclerosing Panencephalitis: A Systematic Review of Case Reports and Case Series

Ravindra Kumar Garg et al. Am J Trop Med Hyg. .

Abstract

Vision loss is a presenting complaint in many patients with subacute sclerosing panencephalitis (SSPE). Data related to vision loss in SSPE is available only in the form of case reports. In this systematic review, we evaluated characteristics of vision loss, affected anatomic site, and patient course and outcome. We extracted data from four databases: PubMed, Embase, Scopus, and Google Scholar. The last search was done on October 26, 2022. We adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The protocol was registered with PROSPERO (CRD42022362652). Dyken's criteria were used for the diagnosis of SSPE. The data were recorded in an Excel sheet. The Joanna Briggs Institute Critical Appraisal tool was used to assess the quality of data. The mean age of patients with SSPE was 17.9 years. Males outnumbered females (60:34). In 73 patients (76%), duration of illness/onset of vision loss was less than 6 months. In 76% patients (n = 73), visual manifestations appeared before encephalopathy. Involvement of the retina (58 of 96, 60.4%), optic nerve (9 of 96, 9.3%), or cerebral cortex (29 of 96, 30.2%) was responsible for vision loss. T2/fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI) parieto-occipital hyperintensities were the most frequent (71.4%) neuroimaging abnormality. Retinal biopsy revealed similar findings revealed by brain histopathology. All patients died and became akinetic mute during the follow-up period, which ranged from a few weeks to a few years. In conclusion, retinal involvement was the most common cause of vision loss. Vision loss often precedes encephalopathy. Cortical vision loss was associated invariably with T2/FLAIR MRI hyperintensities in the parieto-occipital region.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of the study depicts the process of article selection for systematic review. SSPE = subacute sclerosing panencephalitis.
Figure 2.
Figure 2.
Diagram explains possible pathogenetic mechanisms responsible for brain and retinal damage.
Figure 3.
Figure 3.
Sketch diagram depicts that visual changes start primarily from the retina. Subsequently, other structures such as the optic nerve head and choroid layer are involved.

References

    1. Garg RK, Mahadevan A, Malhotra HS, Rizvi I, Kumar N, Uniyal R, 2019. Subacute sclerosing panencephalitis. Rev Med Virol 29: e2058. - PubMed
    1. Garg RK, Paliwal VK, Rizvi I, Kumar N, Agrawal AA, Agrawal P, 2022. Vision Loss in Patients of Subacute Sclerosing Panencephalitis (SSPE): A Systematic Review of Case Reports and Case Series. Available at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022362652. Accessed April 17, 2023. - PMC - PubMed
    1. Dyken PR, 1985. Subacute sclerosing panencephalitis: current status. Neurol Clin 3: 179–196. - PubMed
    1. The Joanna Briggs Institute , 2017. The Joanna Briggs Institute Critical Appraisal Tools for Use in JBI Systematic Reviews: Checklist for Case Reports. Available at: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Ch.... Accessed April 17, 2023.
    1. World Health Organization , 2006. Subacute sclerosing panencephalitis and measles vaccination. GACVS meeting, of December 1–2, 2005. Available at: https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/t.... Accessed March 4, 2023.

LinkOut - more resources